WuXi Biologics Training Case study

WuXi Biologics

On a green-field site near Dundalk, equidistant from Dublin and Belfast on Ireland’s east coast, WuXi Biologics, a leading global open-access biologics technology platform company, is constructing ‘The Factory of the Future’ for biologics manufacturing.

WuXi Biologics have invested in excess of €1 billion on their campus in Dundalk. Construction continued throughout 2021 with an on-site average of 1,800 workers during peak construction months.

Immediately close-by on an adjoining site, its subsidiary WuXi Vaccines recently announced plans to establish a major vaccines facility on the WuXi Biologics Dundalk Campus, to employ an additional 200 people when it goes operational in 2024.

WuXi picture

''Dundalk is ideally placed equidistant between Dublin and Belfast. It is also within easy reach of 10 Universities and HEIs including NIBRT. The other big attraction in Ireland is that the talent pipeline is so strong. We’ve been able to recruit all the talent we require to date, and we are confident of filling all remaining roles in time for full production in 2022. That's a tribute to Ireland’s education system and to institutes like NIBRT''

Brendan McGrath, Vice President of Manufacturing WuXi Biologics

Offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing, WuXi Biologics’ services are designed to accelerate and transform the discovery, development and manufacturing process for the latest generation of biopharmaceutical drugs, whilst also reducing the cost of production. WuXi Biologics will use the new Dundalk facility to ensure that its innovative manufacturing technology is accessible to global clients producing leading medicines in an EU regulated environment.